Respiratory Disease Testing Market Share & Size Report, 2032

The respiratory disease testing market was worth USD 14 billion in 2022 and is anticipated to exhibit 6.5% CAGR from 2023-2032 owing to rising burden of pulmonary and hospital-acquired infections.

2022年，呼吸疾病检测市场价值高达140亿美元，预计从2023年至2032年将以6.5%的复合年增长率发展，此增长趋势得益于肺源性和医院获得性感染的负担日益加重。